Citalopram NDC 43063-063

NDC codes

FDA NDC Directory

Product NDC (as listed)43063-063Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43063-0063Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
43063-063-14	43063006314	14 TABLET in 1 BOTTLE, PLASTIC (43063-063-14)Marketed from Aug 21, 2012
43063-063-30	43063006330	30 TABLET in 1 BOTTLE, PLASTIC (43063-063-30)Marketed from Aug 21, 2012
43063-063-60	43063006360	60 TABLET in 1 BOTTLE, PLASTIC (43063-063-60)Marketed from Aug 21, 2012
43063-063-90	43063006390	90 TABLET in 1 BOTTLE, PLASTIC (43063-063-90)Marketed from Aug 21, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Citalopram
Generic name (nonproprietary): citalopram
Active ingredients: Citalopram hydrobromide — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PD-Rx Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077289
Marketing start: Apr 6, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 43063-063_2b24d618-2b9f-f54e-e063-6394a90a9c46SPL ID 2b24d618-2b9f-f54e-e063-6394a90a9c46SPL set ID 75f6db65-e4ed-470a-9e56-12791f22ee9bRxCUI 200371UNII I1E9D14F36UPC 0343063221013
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443063006314 followed by a unit qualifier and the quantity

Package 43063-0063-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 7, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Citalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077289

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077289
Product	Strength	Form · route	Labeler	Product NDC
Citalopram	Citalopram hydrobromide 40 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-054
Citalopram	Citalopram hydrobromide 10 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-052
Citalopram	Citalopram hydrobromide 20 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-053